Latest Breaking News On - Carsten brunn - Page 1 : comparemela.com

Cartesian Therapeutics, Inc : Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Cartesian Therapeutics, Inc : Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDavid rosenCarsten brunnRon moldaverExchange commissionCartesian therapeutics incDrug administrationCompany on linkedinCompany seriesa nonAmerican society of geneChief executive officerPipeline progressMyasthenia gravisOrphan drug designationAmerican societyCell therapy

Cartesian Therapeutics Highlights Progress and 2024

Topline data from Phase 2b study of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy in myasthenia gravis (MG) remains on track.

United statesMelissa forstCarsten brunnDavid rosenCompany phaseProgram updatesDrug administrationExchange commissionCompany seriesa nonCartesian therapeutics incChief executive officerOrphan drug designationNon voting convertible preferred stockPrivate securities litigation reform actAnnual reportQuarterly reports

Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity

Topline data from Phase 2b study of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy in myasthenia gravis remains on track for mid-2024 Positive 12-month.

United statesDavid rosenMelissa forstCarsten brunnGlobenewswire incCompany seriesa nonCompany phaseExchange commissionCartesian therapeutics incProgram updatesDrug administrationChief executive officerOrphan drug designationNon voting convertible preferred stockPrivate securities litigation reform actAnnual report

Selecta Biosciences (SELB) to Merge with Cartesian Therapeutics

Selecta Biosciences (SELB) to Merge with Cartesian Therapeutics
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Blaine davisTimothy springerCarsten brunnMilos miljkovicCarries coxMetin kurtogluMatthew bartholomaeChris jewellMurat kalayogluTimothya springerCovington burlingFoley hoagCartesian therapeutics incCompany nasdaqCartesian coDrug administration

Selecta Biosciences Announces Merger with Cartesian Therapeutics

13.11.2023 - – Merger creates a fully integrated, publicly traded company pioneering RNA cell therapy for the treatment of autoimmune disease – – Cartesian’s wholly owned pipeline includes a Phase 2 lead asset, Descartes-08, for which deep and durable responses . Seite 1

Carsten brunnMurat kalayogluTimothya springerCartesian coSelecta biosciences incCartesian therapeutics incCompany nasdaqCartesian co founders murat kalayogluMichael singerLegacy selectaContingent value rightsCartesian therapeuticsSelecta boardChief executiveSelecta biosciences chartElecta biosciences kurs